Dosidal · Belgium
Xanthium - 400 400 mg
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:138564-03 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | be-cti-extended: 138564-03 be-authorisation: BE138564 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: AUTHORIZED ampp_status: AUTHORIZED commercialised_now: False lifecycle: current period_from: 2025-03-03 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM138564-00 atc: R03DA04 authorisation_number: BE138564 cti_extended: 138564-03 form: Prolonged-release capsule, hard holder: Laboratoires S.M.B. medicine_type: ALLOPATHIC name: Xanthium - 400 400 mg pack: 100 (100 x 1) parallel_circuit: 0 parallel_import: False substances: substance: Theophylline Monohydrate state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | fmd_in_scope: True note: no FMD product code and no CNK in SAM state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53avXJ_zlphGklkKbVpVjBS7JApV0okYL__VWy1OydLieekFV3oB-fPXAjR7_Q4EU69wuYAo8nb5_Len02ZZVzPgVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:138564-03 · Related records in other markets · Dosidal